Drupal.behaviors.print = function(context) {window.print();window.close();}>

Santaris, Miragen Form miRNA Drug Alliance

June 24, 2010

Santaris, Miragen Form miRNA Drug Alliance

Miragen will have the right to use Santaris' locked nucleic acid technology in the development of drugs targeting miRNAs related to cardiovascular disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories